Skip to main content
Clinical Trials/ACTRN12622001374752
ACTRN12622001374752
Not yet recruiting
Phase 3

Characteristic Changes of Visual Function using Atropine Eye Drops in Adult Myopes.

nversity of New South Wales -UNSW0 sites15 target enrollmentOctober 26, 2022

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
nversity of New South Wales -UNSW
Enrollment
15
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 26, 2022
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
nversity of New South Wales -UNSW

Eligibility Criteria

Inclusion Criteria

  • Aged between 18\-35 years .
  • Have normal general and eye health.
  • Have an optical prescription between \-0\.50 and \-4\.00D; with less than \-1\.50D of astigmatism.
  • Have ‘normal’ vision, measuring 6/7\.5 or better with correction (0,2 LogMar).
  • Have a normal color vision.
  • Have normal intraocular pressure (IOP).
  • Willing to attend two study visits.

Exclusion Criteria

  • Have used an atropine eye drop within 2 weeks prior to study enrolment.
  • Have any eye diseases including inflammation, infection, or allergy.
  • Have a history of allergic reactions to eye medications.
  • Are at risk of glaucoma.
  • Are currently using any eye medications or antidepression.
  • Women who are pregnant, planning to become pregnant, or breastfeeding.

Outcomes

Primary Outcomes

Not specified

Similar Trials